For a detailed overview, see Tirzepatide Injections at Geneva Med Spa
Thus, in patients with type 2 diabetes, combination incretin therapy is poised to provide better glycemic efficacy than treatment with a GLP-1 receptor agonist alone while maintaining a good side-effect profile with respect to avoiding hypoglycemia. As Healio previously reported, top-line data from SURPASS-4, the largest and longest trial of the program to date, also demonstrated that tirzepatide significantly reduced HbA1c and body weight compared with insulin glargine (Lantus, Sanofi) for adults with type 2 diabetes at high cardiovascular risk
Regardless, as they increase in popularity, they will likely change the GLP-1 industry
However, for patients who are afraid of needles or dislike injections, the difference may be small enough that sublingual semaglutide is a preferable choice
At 30mg/mL, you need just 16.7 units